Prometheus' genetic testing for inflammatory bowel disease gets US patent
Thursday, October 22, 2009 14:00 IST San Diego
Prometheus Laboratories Inc, a specialty pharmaceutical and diagnostic company, has been awarded US Patent No. 7,592,437 by the US Patent and Trademark Office.